Free Trial
NASDAQ:OCEA

Ocean Biomedical (OCEA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.41
$1.48
50-Day Range
N/A
52-Week Range
N/A
Volume
49,191 shs
Average Volume
276,853 shs
Market Capitalization
$50.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.63

Ocean Biomedical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,099.3% Upside
$17.63 Price Target
Short Interest
Healthy
7.56% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Ocean Biomedical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.53 out of 5 stars

Medical Sector

511th out of 928 stocks

Pharmaceutical Preparations Industry

237th out of 437 stocks

About Ocean Biomedical

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

OCEA Stock News Headlines

Ocean Biomedical, Inc. (OCEA)
AGW-Mental Wellbeing 2024 - Mid-size companies
OCEA May 2024 7.500 call
OCEA May 2024 2.500 put
See More Headlines
Receive OCEA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
6/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OCEA
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.63
High Stock Price Target
$17.63
Low Stock Price Target
$17.63
Potential Upside/Downside
+1,099.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-960,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($2.26) per share

Miscellaneous

Free Float
9,182,000
Market Cap
$50.94 million
Optionable
Optionable
Beta
1.64
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

OCEA Stock Analysis - Frequently Asked Questions

Should I buy or sell Ocean Biomedical stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ocean Biomedical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" OCEA shares.
View OCEA analyst ratings
or view top-rated stocks.

What is Ocean Biomedical's stock price target for 2024?

1 Wall Street analysts have issued 1 year target prices for Ocean Biomedical's shares. Their OCEA share price targets range from $17.63 to $17.63. On average, they anticipate the company's share price to reach $17.63 in the next twelve months. This suggests a possible upside of 1,099.3% from the stock's current price.
View analysts price targets for OCEA
or view top-rated stocks among Wall Street analysts.

When did Ocean Biomedical IPO?

Ocean Biomedical (OCEA) raised $22 million in an initial public offering on the week of April 18th 2022. The company issued 2,000,000 shares at $10.00-$12.00 per share. Roth Capital Partners and JonesTrading acted as the underwriters for the IPO.

This page (NASDAQ:OCEA) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners